News

x 

Three students with ties to the School were finalists in the event, which challenges graduate students to explain their research to an audience of non-experts in just three minutes.

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

The 2024 Bowes Biomedical Investigator has been named, set to explore new scientific directions such as the intersection of GPCR research and neuropsychiatric diseases.

The GPCR and neuropsychiatric diseases researcher will receive $1.25 million over five years to explore new territory.

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the School’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

An emeritus faculty member and UCSF Medal winner who pushed the field of pharmaceutical chemistry into the computational era passed away after his 90th birthday.

Computational biology and protein engineering expert will focus on cultivating collaboration.

QBI publishes breakthrough on COVID-19 variants; Nevan Krogan recognized as trailblazer.

Dean Kathy Giacomini shares how the School’s recent breakthroughs and accomplishments are bringing our new strategic plan to life.

This ninth year of awards focuses on research advancing health and furthering understanding related to cancer, diabetes, HIV testing, immune response, and more.

Award from her alma mater recognizes Giacomini as a leading scientist and pharmacogenomics expert.

Honoring the School’s newest PharmD graduates.

PSPG and BMI graduate students will bring their scientific talents and passion for equity to Genentech during their summer internships.

UCSF researchers capture the first images of an odorant binding to an olfactory receptor.

Funding from the Mark Foundation for Cancer Research will fuel high-risk, high-impact research on uveal melanoma.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 43rd consecutive year.